Avoiding controversy in international provision of subdermal contraceptive implants

Contraception

Volumn 85, Issue 5, 2012, Pages 432-433

  Hubacher, David ^a   Dorflinger, Laneta ^a  

^a FHI360 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETONOGESTREL; LEVONORGESTREL;

AFRICA SOUTH OF THE SAHARA; CONTRACEPTION; DEMOGRAPHY; DEVICE REMOVAL; EDITORIAL; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMPLANT; REPRODUCTION; REPRODUCTIVE HEALTH; SUBDERMAL CONTRACEPTIVE IMPLANT;

AFRICA SOUTH OF THE SAHARA; ATTITUDE TO HEALTH; CONTRACEPTIVE AGENTS, FEMALE; DEVELOPING COUNTRIES; DRUG COSTS; DRUG IMPLANTS; FEMALE; HEALTH POLICY; HUMANS; INTERNATIONAL AGENCIES; MALE; TREATMENT REFUSAL;

EID: 84859701127     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2011.11.018     Document Type: Editorial

References (4)

1. Reproductive Health Supplies Coalition RHInterchange Web site Accessed on October 22, 2011 at http://rhi.rhsupplies.org/rhi/index.do?locale=en-US
2. N. Corby, T. Boler, and D. Hovig The MSI Impact Calculator: methodology and assumptions 2009 Marie Stopes International London Accessed on October 22, 2011 at www.mariestopes.org
3. United Nations Department of Economic and Social Affairs World Contraceptive Use Accessed on October 22, 2011 http://www.un.org/esa/population/ publications/contraceptive2011/contraceptive2011.htm3
4. ICF Macro Demographic and Health Surveys Retrieved October 22, 2011, from http://www.measuredhs.com/